SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma reports 11-fold rise in Q3 net profit

08 Feb 2013 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2012.

The company has posted 11-fold rise in its net profit of Rs 144.28 crore for the quarter as compared to Rs 12.93 crore for the same quarter in the previous year.  Total income from operation of the company has increased by 19.01% at Rs 1432.45 crore for quarter under review as compared to Rs  1203.61 crore for the quarter ended December 31, 2011.

On consolidated basis, the company has reported a net profit of Rs 91.81 crore for the quarter as compared to a net loss of Rs 28.54 crore for the same quarter in the previous year. Total income of the company has increased by 22.17% at Rs 1575.73 crore for quarter under review as compared to Rs 1289.74 crore for the quarter ended December 31, 2011.

Aurobindo Pharma Share Price

1389.55 -6.95 (-0.50%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×